PGC1A Gene

PGC1A Gene

Introduction

Pgc1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-gene">
| | |
|---|---|
| Gene Symbol | PGC1A |
| Full Name | PPARG Coactivator 1 Alpha |
| Chromosomal Location | 4p15.1 |
| NCBI Gene ID | [10887](https://www.ncbi.nlm.nih.gov/gene/10887) |
| Ensembl ID | [ENSG00000100739](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100739) |
| UniProt ID | [Q9UBX3](https://www.uniprot.org/uniprot/Q9UBX3) |
| Associated Diseases | [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [Huntington's Disease](/diseases/huntingtons), [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis), [Metabolic Syndrome](/diseases/metabolic-syndrome) |
</div>

Overview

PGC1A Gene

Introduction

Pgc1A Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-gene">
| | |
|---|---|
| Gene Symbol | PGC1A |
| Full Name | PPARG Coactivator 1 Alpha |
| Chromosomal Location | 4p15.1 |
| NCBI Gene ID | [10887](https://www.ncbi.nlm.nih.gov/gene/10887) |
| Ensembl ID | [ENSG00000100739](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100739) |
| UniProt ID | [Q9UBX3](https://www.uniprot.org/uniprot/Q9UBX3) |
| Associated Diseases | [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), [Huntington's Disease](/diseases/huntingtons), [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis), [Metabolic Syndrome](/diseases/metabolic-syndrome) |
</div>

Overview

PPARG Coactivator 1 Alpha (PGC-1alpha) is a transcriptional coactivator that serves as a master regulator of mitochondrial biogenesis and cellular energy metabolism [1]. Encoded by the PGC1A gene, this protein coordinates the expression of genes involved in oxidative phosphorylation, fatty acid oxidation, and adaptive thermogenesis [2]. PGC-1alpha is particularly important in tissues with high energy demands, including skeletal muscle, cardiac muscle, and the brain [3].

Molecular Function

PGC-1α functions as a versatile transcriptional coactivator that interacts with multiple transcription factors to regulate gene expression:

Protein Structure

• N-terminal activation domain: Interacts with nuclear receptors and other transcription factors [4]
• RS domain: Contains arginine/serine-rich regions involved in RNA processing [5]
• C-terminal domain: Mediates protein-protein interactions with transcriptional machinery [6]

Transcriptional Targets

PGC-1α coactivates numerous transcription factors:

• PPARγ: Peroxisome proliferator-activated receptor gamma, regulating adipogenesis and lipid metabolism [7]
• NRF-1/NRF-2: Nuclear respiratory factors, activating mitochondrial transcription factors [8]
• ERRα: Estrogen-related receptor alpha, controlling oxidative metabolism genes [9]
• TFAM: Mitochondrial transcription factor A, directly regulating mitochondrial DNA transcription [10]
• SIRT1: Deacetylase that activates PGC-1α through deacetylation [11]

Signaling Pathways

• AMPK activation: Cellular energy deficit activates PGC-1α through phosphorylation [12]
• SIRT1 activation: NAD+-dependent deacetylase activates PGC-1α in response to caloric restriction [13]
• p38 MAPK pathway: Stress-activated kinase phosphorylates and activates PGC-1α [14]
• cAMP/PKA pathway: Glucagon and adrenaline signaling can activate PGC-1α [15]

Expression Pattern

• Tissue distribution: Highest expression in skeletal muscle, heart, brown adipose tissue, and kidney [16]
• Brain expression: Detected in cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and substantia nigra [17]
• Cell-type specificity: Expressed in [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and oligodendrocytes [18]
• Regulation: Highly responsive to environmental and hormonal signals [19]

Role in Neurodegeneration

Parkinson's Disease

• PGC-1α expression is significantly reduced in substantia nigra dopaminergic neurons of PD patients [20]
• Loss of PGC-1α leads to mitochondrial dysfunction and increased susceptibility to PD-like pathology [21]
• PGC-1α knockout mice show enhanced sensitivity to MPTP-induced dopaminergic neurodegeneration [22]
• Gene therapy with PGC-1α protects against dopaminergic neuron loss in models [23]
• PGC-1α downregulation in PD is mediated by abnormal α-synuclein accumulation [24]

Alzheimer's Disease

• PGC-1α levels reduced in AD brain, correlating with cognitive decline [25]
• Amyloid-beta toxicity downregulates PGC-1α through epigenetic mechanisms [26]
• PGC-1α activation protects against [Aβ](/proteins/amyloid-beta)-induced mitochondrial dysfunction [27]
• Impaired mitochondrial biogenesis contributes to synaptic loss in AD [28]

Huntington's Disease

• PGC-1α is severely downregulated in HD brain and cellular models [29]
• Mutant [huntingtin](/proteins/huntingtin) directly represses PGC-1α transcription [30]
• PGC-1α deficiency contributes to mitochondrial dysfunction and striatal degeneration [31]
• Enhancing PGC-1α expression improves motor function and survival in HD models [32]

Amyotrophic Lateral Sclerosis

• Reduced PGC-1α expression in ALS spinal cord and muscle [33]
• PGC-1α protects motor neurons from oxidative stress and mitochondrial dysfunction [34]
• Exercise-induced PGC-1α upregulation may have therapeutic potential in ALS [35]

Therapeutic Implications

Small Molecule Activators

• Resveratrol: SIRT1 activator that increases PGC-1α activity [36]
• Metformin: AMPK activator that induces PGC-1α expression [37]
• AICAR: Direct AMPK agonist [38]

Gene Therapy Approaches

• AAV-mediated PGC-1α delivery shows promise in preclinical models [39]
• Exercise and lifestyle interventions naturally upregulate PGC-1α [40]

Key Publications

Background

The study of Pgc1A Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

<references />

See Also

• [PGC1A Protein](/proteins/pgc1a-protein)
• [Mitochondrial Biogenesis Pathway](/content/genes)
• [Parkinson's Disease](/diseases/parkinsons-disease-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [SIRT1 Pathway](/entities/sirt1)

External Links

• [NCBI Gene: PGC1A](https://www.ncbi.nlm.nih.gov/gene/10887)
• [UniProt: PGC1A](https://www.uniprot.org/uniprot/Q9UBX3)
• [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000100739-PGC1A)
• [OMIM: PGC1A](https://www.omim.org/entry/604517)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits](/hypothesis/h-827a821b) — <span style="color:#ffd54f;font-weight:600">0.53</span> · Target: PGC1A, SIRT1, FOXO3, mitochondrial biogenesis genes

Pathway Diagram

The following diagram shows the key molecular relationships involving PGC1A Gene discovered through SciDEX knowledge graph analysis: